Bivin & Associates’s inTEST INTT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1K Buy
91
+2
+2% +$16 ﹤0.01% 273
2022
Q1
$1K Hold
89
﹤0.01% 301
2021
Q4
$1K Buy
+89
New +$1.15K ﹤0.01% 321

Other funds holding INTT

Bivin & Associates's INTT Position: Q2 2022 in Review

Bivin & Associates increased its inTEST (INTT) stake by 2.2% in Q2 2022, buying an estimated $16 and bringing the position to 91 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #273.

Bivin & Associates first reported a position in INTT in Q4 2021 and has held it in 3 quarters since. 48 funds tracked by Wall St. Rank hold INTT as of Q2 2022.

  • Bivin & Associates held 91 shares of inTEST worth $1K as of Q2 2022.
  • Bivin & Associates bought 2 inTEST shares in Q2 2022, an estimated $16.
  • inTEST made up ﹤0.01% of Bivin & Associates's portfolio in Q2 2022, its #273 holding.
  • Bivin & Associates first reported a position in inTEST in Q4 2021 and has held it in 3 quarters since.
  • 48 funds tracked by Wall St. Rank held inTEST as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.